U.S. markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
211.66-1.37 (-0.64%)
At close: 04:00PM EDT
211.16 -0.50 (-0.24%)
After hours: 06:30PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close213.03
Bid207.40 x 1200
Ask211.40 x 1000
Day's Range208.62 - 213.58
52 Week Range208.62 - 317.17
Avg. Volume576,004
Market Cap19.134B
Beta (5Y Monthly)1.07
PE Ratio (TTM)10.18
EPS (TTM)20.79
Earnings DateOct 26, 2022 - Oct 31, 2022
Forward Dividend & Yield2.88 (1.36%)
Ex-Dividend DateAug 17, 2022
1y Target Est303.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Laboratory Corporation of Ameri
    Analyst Report: Laboratory Corp. Of America HlLabCorp operates one of the largest global clinical laboratory networks, managing more than 160 million patient encounters each year, or more than 3 million patient specimens per week. LabCorp also supports clinical trial activity in approximately 100 countries through its central laboratory, preclinical, and clinical development businesses. With a market cap of about $26 billion, LH shares are generally regarded as large-cap growth. The company is a component of the S&P 500 and employs over 75,500 people.
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more